LBA-5 Phase Ib study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in patients with metastatic esophageal cancer
Titel:
LBA-5 Phase Ib study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in patients with metastatic esophageal cancer
Auteur:
Wainberg, Z. Matos, I. Delord, J. Cassier, P. Gil-Martin, M. Kim, T. LoRusso, P. Bahleda, R. Italiano, A. Mendus, D. Hoang, T. Xue, C. Wen, X. Carvalho, O. Pham, T. Patil, N. Meng, R. Bendell, J. Cervantes, A. Cho, B.